Ingevity NGVT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $258M+4.1% | $255.1M-3.1% | $333.1M-0.2% | $365.1M-6.5% | $247.9M-27.1% | ||
| $141.6M+4.1% | $167.3M+2.4% | $199.2M-1.5% | $227.2M-15.0% | $136M-43.4% | ||
| $116.4M+4.0% | $87.8M-12.1% | $133.9M+1.7% | $137.9M+11.9% | $111.9M+12.2% | ||
| 45.1%0.0pp | 34.4%-3.5pp | 40.2%+0.8pp | 37.8%+6.2pp | 45.1%+15.8pp | ||
| $6.7M-4.3% | $7.4M+13.8% | $7M+12.9% | $7.8M+6.8% | $7M+2.9% | ||
| $40.7M-2.9% | $41.6M+8.6% | $44.1M+16.4% | $44.2M+6.8% | $41.9M-11.2% | ||
| —— | $27.33M— | $27.33M— | $27.33M— | $27.33M— | ||
| -$22.4M-446% | -$15.5M-15,400% | -$1.2M+81.5% | -$4.3M+82.0% | -$4.1M+87.3% | ||
| -$15.9M+18.0% | $134.7M-19.4% | -$18.4M+22.7% | -$18.6M+19.8% | -$19.4M+13.0% | ||
| —— | $1.3M-32.5% | $1.3M-32.5% | $1.3M-32.5% | $1.3M-32.5% | ||
| $30.2M-19.7% | -$105.4M— | $62.2M+15.2% | -$142.7M+57.4% | $37.6M+152% | ||
| $6.8M-20.0% | —— | $21.4M+229% | $3.8M+107% | $8.5M+153% | ||
| $59.8M+192% | -$84.6M— | $43.5M+141% | -$146.5M+48.4% | $20.5M+137% | ||
| 23.2%+14.9pp | -33.2%-33.2pp | 13.1%+45.2pp | -40.1%+32.5pp | 8.3%+24.7pp | ||
| $0.66-17.5% | -$2.18— | $1.12-14.5% | -$3.89— | $0.80— | ||
| $1.04+533% | -$0.16-100.0% | $0.08+102% | -$0.14— | -$0.24— | ||
| $1.66+196% | -$2.34— | $1.18+140% | -$4.02+48.5% | $0.56+136% | ||
| $1.70+204% | -$2.34— | $1.20+141% | -$4.02+48.5% | $0.56+136% | ||
| -$15.9M+18.0% | —— | -$18.4M+22.7% | -$18.6M+19.8% | -$19.4M+13.0% | ||
| $0.66-17.5% | -$2.18— | $1.12-14.5% | -$3.89— | $0.8— | ||
| $0.65-17.7% | -$2.18— | $1.1-15.4% | -$3.86— | $0.79— | ||
| $1.01+539% | -$0.16-100.0% | $0.08+102% | -$0.15— | -$0.23— | ||
| —— | $27.33M— | $27.33M— | $27.33M— | $27.33M— | ||
| $23.4M-19.6% | -$78.8M— | $40.8M-14.1% | -$141.4M— | $29.1M— | ||
| -$22.4M-446% | -$15.5M-15,400% | -$1.2M+81.5% | -$4.3M+82.0% | -$4.1M+87.3% | ||
| $500K-73.7% | $2.7M-72.4% | $1M-69.7% | $21.9M+67.2% | $1.9M-97.0% | ||
| $258M+4.1% | $255.1M-3.1% | $333.1M-0.2% | $365.1M-6.5% | $247.9M-27.1% | ||
| $14.3M-21.4% | $29.3M— | $43.8M+45.0% | -$161.3M+54.9% | $18.2M+119% | ||
| $37M-14.2% | $57.2M— | $71.8M+27.3% | -$135.7M+58.9% | $43.1M+167% | ||
| $37M-14.2% | $57.2M— | $71.8M+27.3% | -$135.7M+58.9% | $43.1M+167% | ||
| 14.3%-3.0pp | 22.4%— | 21.6%+4.7pp | -37.2%+47.4pp | 17.4%+36.4pp | ||
| $14.3M-21.4% | $29.3M— | $43.8M+45.0% | -$161.3M+54.9% | $18.2M+119% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Ingevity's revenue?
- Ingevity (NGVT) generated $1.2B in revenue over the trailing twelve months, down 2.0% year over year.
- Is Ingevity profitable?
- Ingevity is not currently profitable: it reported a net loss of $127.8M over the trailing twelve months, a -10.6% net margin.
- What is Ingevity's earnings per share?
- Ingevity's diluted EPS over the trailing twelve months is $-3.52.
- Where does Ingevity's income statement data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
